Wegovy injections for effective weight loss
- • Myweightloss Centre members achieve 3.8x greater weight loss success
- • Average 15% weight loss in 68 weeks
- • Available in 5 graduated dose strengths
- • Starting from £169 per month
What is Wegovy?
Wegovy is a revolutionary weight management medication that works through the targeted action of glucagon-like peptide-1 (GLP-1) receptor agonists to promote sustainable weight loss.
This powerful hormone mimics natural GLP-1 to control appetite, slow gastric emptying, and regulate blood glucose levels, creating optimal conditions for significant weight reduction.
The active ingredient in Wegovy is semaglutide, a proven GLP-1 receptor agonist that has demonstrated remarkable efficacy in clinical trials, with participants achieving an average of 15% body weight reduction over 68 weeks.
How Wegovy works
Our clinically validated Wegovy treatment works by mimicking natural hormones that regulate appetite and metabolism, delivering consistent weight loss results.
Delays gastric emptying
Slows the rate at which food leaves your stomach, promoting lasting satiety
Suppresses appetite
Targets brain receptors to naturally reduce hunger and food cravings
Enhances insulin sensitivity
Improves how your body processes glucose and manages energy storage
Stabilizes blood sugar
Maintains healthy glucose levels and reduces post-meal blood sugar spikes
How much weight can I lose with Wegovy?
Wegovy has demonstrated exceptional weight loss results in extensive clinical research studies.
The landmark STEP clinical trial program involving over 4,500 participants showed that individuals using Wegovy achieved an average of 15% body weight reduction after 68 weeks of treatment.
Wegovy vs Mounjaro
Compare the two leading weight management solutions
Learn More About Wegovy
Watch our detailed guide to Wegovy weight loss treatment
🎥 Coming Soon
Frequently Asked Questions
Using Wegovy
Wegovy is administered as a once-weekly subcutaneous injection. Your healthcare provider will train you on proper injection technique, typically administered in your thigh, abdomen, or upper arm area using the pre-filled pen.
Most common side effects include nausea, diarrhea, vomiting, constipation, and reduced appetite. These gastrointestinal effects usually diminish as your body adapts to the treatment over time.
Many patients experience initial weight loss within 2-4 weeks, with substantial results becoming apparent after 12-16 weeks of consistent treatment following the prescribed dosing schedule.
Wegovy vs Mounjaro
Wegovy contains semaglutide and specifically targets GLP-1 receptors, while Mounjaro contains tirzepatide and activates both GLP-1 and GIP receptors. Wegovy has a longer track record with proven long-term safety and efficacy data.
Yes, switching between weight loss medications is possible under proper medical supervision. Your healthcare provider will create a safe transition plan and monitor your progress throughout the changeover period.
The optimal choice between Wegovy and Mounjaro depends on your unique medical history, weight loss objectives, and individual response to treatment. Schedule a consultation with our medical team to determine which option aligns best with your needs.
Ready to Begin Your Wegovy Weight Loss Journey?
Take the first step towards lasting weight management with our proven Wegovy treatment program.
Book Consultation